Join the Anemia - Sickle Cell group to help and get support from people like you.
Anemia - Sickle Cell News (Page 2)
Related terms: Hemoglobin SS disease (Hb SS), Sickle Cell Anemia, Hemoglobin SS disease, Hb SS, SCD
American Academy of Ophthalmology, Nov. 3-5
The annual meeting of the American Academy of Ophthalmology was held from Nov. 3 to 5 in San Francisco and attracted participants from around the world, including ophthalmologists, optometrists,...
AAO: Research Highlights Vision Issues Seen in Pediatric Sickle Cell Disease
THURSDAY, Nov. 9, 2023 – For pediatric patients with sickle cell disease (SCD), ophthalmologic complications include nonproliferative retinopathy (NPR) and proliferative retinopathy (PR), which...
New Gene Therapy for Sickle Cell Disease Considered Safe, FDA
WEDNESDAY, Nov. 1, 2023 – A new gene therapy for sickle cell disease was deemed safe by a U.S. Food and Drug Administration advisory panel on Tuesday, paving the way for full approval by early...
FDA Advisors Say New Gene Therapy for Sickle Cell Disease, Exa-cel, is Safe
WEDNESDAY, Nov. 1, 2023 -- A new gene therapy for sickle cell disease was deemed safe by a U.S. Food and Drug Administration advisory panel on Tuesday, paving the way for full approval by early ...
New Gene Therapies for Sickle Cell Anemia to be Considered by FDA
MONDAY, Oct. 30, 2023 – Patients with sickle cell disease may soon have two new treatments to try. On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new...
FDA Advisors to Weigh New Gene Therapy for Sickle Cell Anemia
MONDAY, Oct. 30, 2023 -- Patients with sickle cell disease may soon have two new treatments to try. On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new ...
Pneumococcal Infection Reduced in Children With Sickle Cell Since PCV13
TUESDAY, Sept. 19, 2023 – For children with sickle cell disease (SCD), the rates of invasive pneumococcal infection (IPD) have decreased since introduction of pneumococcal conjugate vaccines (PCVs),...
Red Cross Appeals for Donors During National Blood Shortage
MONDAY, Sept. 11, 2023 – The American Red Cross said Monday that it urgently needs blood donations because the national blood supply has dropped nearly 25% since early August. Back-to-back...
Gene-Tweaked Stem Cells Offer Hope Against Sickle Cell Disease
THURSDAY, Aug. 31, 2023 – A type of gene therapy that precisely "edits" a key bit of DNA might offer a new way to treat sickle cell disease – a painful inherited condition that largely strikes...
U.S. FDA Approves Supplemental New Drug Application for Expanded Indication of Oxbryta (voxelotor) for Children as Young as 4 Years of Age with Sickle Cell Disease
New dispersible tablet dosage form also approved Oxbryta is the first medicine that addresses the root cause of red blood cell sickling SOUTH SAN FRANCISCO, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE)...
FDA Approves Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease
SOUTH SAN FRANCISCO, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that the U.S. Food and Drug Administration (FDA) has granted accele...
FDA Approves Adakveo (crizanlizumab-tmca) to Reduce Frequency of Pain Crises in Individuals Living with Sickle Cell Disease
Basel, November 15, 2019 – Novartis announced today that the US Food and Drug Administration (FDA) approved Adakveo (crizanlizumab), previously known as SEG101, to reduce the frequency of v...
FDA Approves Endari (L-glutamine oral powder) for Sickle Cell Disease
July 7, 2017 – The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications...
Ask a question
To post your own question to this support group, sign in or create an account.